• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在印度北部一家转诊中心就诊的格雷夫斯病患者中格雷夫斯眼病的患病率。

Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.

作者信息

Reddy Sagili Vijaya Bhaskar, Jain Anu, Yadav Subhash B, Sharma Kumudini, Bhatia Eesh

机构信息

Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

出版信息

Indian J Med Res. 2014 Jan;139(1):99-104.

PMID:24604044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3994747/
Abstract

BACKGROUND & OBJECTIVES: The prevalence of Graves' ophthalmopathy (GO) varies widely in different ethnic groups. Indians have been reported to have a lower prevalence of Graves' ophthalmopathy as compared to Caucasians of European origin, but data are sparse and inconclusive. We studied the prevalence, clinical features and association of GO in Indian patients with Graves' disease attending a referral centre in north India.

METHODS

A prospective study was conducted on 235 consecutive newly referred north Indian patients with Graves' disease presenting to a tertiary care centre in north India. All patients underwent a comprehensive ophthalmological examination as per the European Group on Graves' Orbitopathy (EUGOGO) recommendations.

RESULTS

GO was diagnosed in 65 patients (prevalence 28%; 95% confidence interval 22-33%). The prevalence was similar in males (28%) and females (27%). It was mild in 83 per cent, moderate-severe in 15 per cent and sight-threatening in only 2 per cent of cases. Ophthalmopathy was clinically active in only two (3%) cases. Upper eyelid retraction was the most common manifestation (83%), followed by exophthalmos (75%). Extra-ocular muscle involvement (5%) and optic nerve dysfunction (2%) were uncommon. The risk of GO was 3.9- fold (95% confidence interval 1.1-13.6) higher in smokers compared to non-smokers. However, severity of disease in smokers was similar to non-smokers. On multivariate logistic regression analysis, GO was associated only with high thyrotropin receptor antibody titres and current smoking.

INTERPRETATION & CONCLUSIONS: Among north Indian patients with GD studied at a referral center, the prevalence of GO was similar to Caucasians of European descent, but clinically active and severe ophthalmopathy was uncommon. More studies are needed to confirm these findings.

摘要

背景与目的

格雷夫斯眼病(GO)在不同种族中的患病率差异很大。据报道,与欧洲裔白种人相比,印度人格雷夫斯眼病的患病率较低,但数据稀少且尚无定论。我们研究了在印度北部一家转诊中心就诊的格雷夫斯病患者中GO的患病率、临床特征及相关性。

方法

对连续转诊至印度北部一家三级医疗中心的235例新诊断的印度北部格雷夫斯病患者进行了一项前瞻性研究。所有患者均按照欧洲格雷夫斯眼眶病研究组(EUGOGO)的建议进行了全面的眼科检查。

结果

65例患者被诊断为GO(患病率28%;95%置信区间22 - 33%)。男性(28%)和女性(27%)的患病率相似。83%的病例病情较轻,15%为中度至重度,仅2%的病例有视力威胁。仅2例(3%)患者的眼病处于临床活动期。上睑退缩是最常见的表现(83%),其次是眼球突出(75%)。眼外肌受累(5%)和视神经功能障碍(2%)并不常见。吸烟者患GO的风险比不吸烟者高3.9倍(95%置信区间1.1 - 13.6)。然而,吸烟者的疾病严重程度与不吸烟者相似。多因素逻辑回归分析显示,GO仅与高促甲状腺素受体抗体滴度和当前吸烟有关。

解读与结论

在印度北部一家转诊中心研究的格雷夫斯病患者中,GO的患病率与欧洲血统的白种人相似,但临床活动期和严重眼病并不常见。需要更多研究来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a106/3994747/85a96c2261b2/IJMR-139-99-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a106/3994747/85a96c2261b2/IJMR-139-99-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a106/3994747/85a96c2261b2/IJMR-139-99-g003.jpg

相似文献

1
Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India.在印度北部一家转诊中心就诊的格雷夫斯病患者中格雷夫斯眼病的患病率。
Indian J Med Res. 2014 Jan;139(1):99-104.
2
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.在一家单中心就诊的大量新诊断 Graves 甲亢患者中 Graves 眼病的患病率和自然病程。
J Clin Endocrinol Metab. 2013 Apr;98(4):1443-9. doi: 10.1210/jc.2012-3873. Epub 2013 Feb 13.
3
Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease.马来西亚多民族格雷夫斯病患者甲状腺相关性眼病的患病率、危险因素及临床特征
Thyroid. 2008 Dec;18(12):1297-301. doi: 10.1089/thy.2008.0044.
4
Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.威胁视力的格雷夫斯眼病:多学科甲状腺眼病门诊 20 年的经验。
Clin Endocrinol (Oxf). 2019 Jan;90(1):208-213. doi: 10.1111/cen.13880. Epub 2018 Nov 19.
5
Prevalence and natural history of Graves' orbitopathy in the XXI century.二十一世纪格雷夫斯眼病的流行率和自然病程。
J Endocrinol Invest. 2013 Jun;36(6):444-9. doi: 10.3275/8937. Epub 2013 Apr 16.
6
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.2021 年欧洲 Graves 眼病专家组(EUGOGO)Graves 眼病医学管理临床实践指南。
Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.
7
Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin.格雷夫斯眼病与吸烟及种族的关系。
Clin Endocrinol (Oxf). 1992 Mar;36(3):291-4. doi: 10.1111/j.1365-2265.1992.tb01445.x.
8
Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.格雷夫斯眼病临床表型的时间趋势:单中心回顾性研究。
J Endocrinol Invest. 2024 Sep;47(9):2177-2184. doi: 10.1007/s40618-024-02332-3. Epub 2024 Mar 15.
9
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center.三级转诊中心潜在甲状腺疾病在格雷夫斯眼病表型中的作用。
Thyroid. 2015 Mar;25(3):347-51. doi: 10.1089/thy.2014.0475. Epub 2015 Feb 11.
10
Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.免疫球蛋白 G4 与格雷夫斯眼病的临床意义。
Thyroid. 2017 Sep;27(9):1185-1193. doi: 10.1089/thy.2017.0126.

引用本文的文献

1
Butyrate Ameliorates Graves' Orbitopathy Through Regulating Orbital Fibroblast Phenotypes and Gut Microbiota.丁酸盐通过调节眼眶成纤维细胞表型和肠道微生物群改善格雷夫斯眼眶病。
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):5. doi: 10.1167/iovs.66.3.5.
2
Are Severe Forms of Thyroid Eye Disease Common in the Indian Population? Clinical Characteristics of 136 Patients from a Tertiary Eye Care Centre.严重形式的甲状腺眼病在印度人群中常见吗?来自一家三级眼科护理中心的136例患者的临床特征
Indian J Endocrinol Metab. 2023 Jan-Feb;27(1):56-61. doi: 10.4103/ijem.ijem_280_21. Epub 2022 Apr 29.
3
Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.

本文引用的文献

1
Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients.韩国患者中与甲状腺相关眼病严重程度相关的危险因素。
Korean J Ophthalmol. 2010 Oct;24(5):267-73. doi: 10.3341/kjo.2010.24.5.267. Epub 2010 Oct 5.
2
Risk factors for development or deterioration of Graves' ophthalmopathy.格雷夫斯眼病发生或恶化的危险因素。
Thyroid. 2010 Jul;20(7):777-83. doi: 10.1089/thy.2010.1634.
3
Graves' ophthalmopathy.格雷夫斯眼病。
甲状腺眼病及其在 Academy IRIS 注册研究中的威胁视力表现:2014-2018 年。
Am J Ophthalmol. 2023 Sep;253:74-85. doi: 10.1016/j.ajo.2023.04.013. Epub 2023 May 17.
4
Hypo vs. hyperthyroid eye disease: is there any difference?甲状腺功能减退症与甲状腺功能亢进症眼病:有何不同?
BMC Ophthalmol. 2023 Feb 10;23(1):58. doi: 10.1186/s12886-023-02806-7.
5
Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves' Disease having Normally Appearing Pretibial Skin: A Case-Control Study.格雷夫斯病患者胫前皮肤外观正常情况下甲状腺皮肤病变的组织病理学证据及其与甲状腺相关眼病的相关性:一项病例对照研究
Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):141-148. doi: 10.4103/ijem.ijem_504_21. Epub 2022 Jun 6.
6
Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.甲状腺眼病最新进展:患病率、诊断和治疗的地域差异。
Indian J Ophthalmol. 2022 Jul;70(7):2335-2345. doi: 10.4103/ijo.IJO_3217_21.
7
Ophthalmological profile of adult thyroid disease in Southern India.印度南部成人甲状腺疾病的眼科概况。
Indian J Ophthalmol. 2022 Jun;70(6):2201-2202. doi: 10.4103/ijo.IJO_238_22.
8
Orbital Signaling in Graves' Orbitopathy.眼眶信号在格雷夫斯眼病中的作用。
Front Endocrinol (Lausanne). 2021 Nov 9;12:739994. doi: 10.3389/fendo.2021.739994. eCollection 2021.
9
Expression of Endogenous Putative TSH Binding Protein in Orbit.眼眶中内源性 TSH 结合蛋白的表达
Curr Issues Mol Biol. 2021 Oct 27;43(3):1794-1804. doi: 10.3390/cimb43030126.
10
Graves' Orbitopathy: Report of 82 cases.格雷夫斯眼病:82 例报告。
Tunis Med. 2021 Feb;99(2):243-251.
N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750.
4
Clinical practice. Graves' ophthalmopathy.临床实践。格雷夫斯眼病。
N Engl J Med. 2009 Mar 5;360(10):994-1001. doi: 10.1056/NEJMcp0806317.
5
Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves' disease.马来西亚多民族格雷夫斯病患者甲状腺相关性眼病的患病率、危险因素及临床特征
Thyroid. 2008 Dec;18(12):1297-301. doi: 10.1089/thy.2008.0044.
6
Clinical practice. Graves' disease.临床实践。格雷夫斯病。
N Engl J Med. 2008 Jun 12;358(24):2594-605. doi: 10.1056/NEJMcp0801880.
7
Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.放射性碘治疗(RAI)用于格雷夫斯病(GD)及其对眼病的影响:一项系统评价。
Clin Endocrinol (Oxf). 2008 Dec;69(6):943-50. doi: 10.1111/j.1365-2265.2008.03279.x. Epub 2008 Apr 21.
8
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.欧洲Graves眼病专家组(EUGOGO)关于Graves眼病管理的共识声明。
Eur J Endocrinol. 2008 Mar;158(3):273-85. doi: 10.1530/EJE-07-0666.
9
Cigarette smoking and thyroid eye disease: a systematic review.吸烟与甲状腺眼病:一项系统综述。
Eye (Lond). 2007 Sep;21(9):1135-45. doi: 10.1038/sj.eye.6702603. Epub 2006 Sep 15.
10
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers.格雷夫斯眼眶病患者的临床评估:欧洲格雷夫斯眼眶病研究小组给全科医生、专科医生和临床研究人员的建议
Eur J Endocrinol. 2006 Sep;155(3):387-9. doi: 10.1530/eje.1.02230.